TAR-200-Monotherapie
TAR-200-Monotherapie zeigt vollständige Ansprechrate von über 80 Prozent bei Patienten mit nicht-muskelinvasivem Hochrisiko-Harnblasenkarzinom
May 10, 2024 06:44 ET | Janssen Cilag International NV
Neue Daten aus der Phase-IIb-Studie SunRISe-1 zeigen schnelles Erreichen eines vollständigen Ansprechens (Complete Response, CR) mit 98 Prozent der Patienten, die innerhalb von 12 Wochen eine CR...
La monoterapia con T
La monoterapia con TAR-200 mostra un tasso di risposta completa superiore all’80 per cento nei pazienti con tumore della vescica non muscolo-invasivo ad alto rischio
May 10, 2024 06:44 ET | Janssen Cilag International NV
I nuovi dati dello studio di Fase 2b SunRISe-1 mostrano un rapido raggiungimento della risposta completa (CR), con il 98 per cento dei pazienti che raggiunge la CR entro 12 settimane1 TAR-200...
La monoterapia con T
La monoterapia con TAR-200 muestra una tasa de respuesta completa superior al 80 por ciento en pacientes con cáncer de vejiga no músculo-invasivo de alto riesgo
May 10, 2024 06:44 ET | Janssen Cilag International NV
Los nuevos datos del estudio de Fase 2b SunRISe-1 muestran una rápida consecución de la respuesta completa (RC), con un 98 por ciento que logra una RC en 12 semanas1 TAR-200 proporciona una RC...
Le TAR-200 en monoth
Le TAR-200 en monothérapie montre un taux de réponse complète supérieur à 80 pour cent chez les patients atteints d’un cancer de la vessie n’infiltrant pas le muscle à haut risque
May 10, 2024 06:43 ET | Janssen Cilag International NV
Les nouvelles données issues de l’étude de Phase IIb SunRISe-1 montrent l’obtention rapide d’une réponse complète (RC), 98 pour cent des patients ayant présenté une RC dans les 12 semaines1 Le...
logo (3).jpg
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
May 10, 2024 06:40 ET | Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...
22157.jpg
Local General Freight Trucking Global Market Report 2024-2028 & 2032
May 10, 2024 06:38 ET | Research and Markets
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Local General Freight Trucking Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The local general freight trucking...
logo (3).jpg
Man Group PLC : Form 8.3 - Tyman plc
May 10, 2024 06:36 ET | Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...
Centogene_Logo.png
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
May 10, 2024 06:30 ET | Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 10, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Chart logo with Cooler By Design_R.jpg
Chart Industries to Participate in Investor Events
May 10, 2024 06:30 ET | Chart Industries, Inc.
ATLANTA, May 10, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global solutions provider to clean energy and industrial gas markets, announces the participation...
Astute_Analytica_Logo (PNG) (3).png
Asia Pacific Gallium Arsenide Wafer Market to Reach USD 2,635.2 Million By 2032, at 16.6% CAGR: Astute Analytica
May 10, 2024 06:30 ET | AstuteAnalytica India Pvt. Ltd.
New Delhi, May 10, 2024 (GLOBE NEWSWIRE) -- The Asia Pacific gallium arsenide wafer market reached a valuation of US$ 661.5 million in 2023 and is expected to reach US$ 2,635.2 million by 2032,...